Skip to content
2000
Volume 5, Issue 4
  • ISSN: 1573-4064
  • E-ISSN: 1875-6638

Abstract

Because of their high resistance rate to the existing drugs, influenza A viruses have become a threat to human beings. It is known that the replication of influenza A viruses needs a pH-gated proton channel, the so-called M2 channel. Therefore, to develop effective drugs against influenza A, the most logic strategy is to inhibit the M2 channel. Recently, the atomic structure of the M2 channel was determined by NMR spectroscopy (Schnell, J.R. and Chou, J.J., Nature, 2008, 451,591-595). The high-resolution NMR structure has provided a solid basis for structure-based drug design approaches. In this study, a benchmark dataset has been constructed that contains 34 newly-developed adamantane-based M2 inhibitors and covers considerable structural diversities and wide range of bioactivities. Based on these compounds, an in-depth analysis was performed with the newly developed fragment-based quantitative structure-activity relationship (FB-QSAR) algorithm. The results thus obtained provide useful insights for dealing with the drug-resistant problem and designing effective adamantane-based antiflu drugs.

Loading

Article metrics loading...

/content/journals/mc/10.2174/157340609788681430
2009-07-01
2025-05-24
Loading full text...

Full text loading...

/content/journals/mc/10.2174/157340609788681430
Loading

  • Article Type:
    Research Article
Keyword(s): amantadine; drug design; FB-QSAR; influenza A; M2 protein; rimantadine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test